Showing results (11-20 of 66) with videos related to
Sort By:
Pageof 7
Molecules (Basel, Switzerland)|February 25, 2022
Identification of New Regulators of Pancreatic Cancer Cell Sensitivity to Oxaliplatin and CisplatinVera Skripova, Ramilia Vlasenkova, Yan Zhou, et al.Expert Opinion on Therapeutic Targets|November 21, 2007
Selective Raf inhibition in cancer therapyVladimir Khazak, Igor Astsaturov, Ilya G Serebriiskii, et al.Expert Opinion on Investigational Drugs|April 8, 2017
Perspectives of HER2-targeting in gastric and esophageal cancerJames N Gerson, Sam Skariah, Crystal S Denlinger, et al.Computational Biology and Chemistry|April 3, 2026
DoTT-ML: Condition-aware detection of transcriptional readthrough from RNA-seq with optional ML-based prioritizationMichael Levin, Aizhan Surumbayeva, Max Li, et al.The Lancet. Oncology|September 3, 2013
Aurora kinases in head and neck cancerRanee Mehra, Ilya G Serebriiskii, Barbara Burtness, et al.Cellular Signalling|March 5, 2009
Targeting EGFR resistance networks in head and neck cancerVladimir Ratushny, Igor Astsaturov, Barbara A Burtness, et al.Cellular and Molecular Life Sciences : CMLS|August 7, 2012
Aurora A kinase (AURKA) in normal and pathological cell divisionAnna S Nikonova, Igor Astsaturov, Ilya G Serebriiskii, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 14, 2014
Successful imatinib therapy for neuroendocrine carcinoma with activating Kit mutation: a case studyJames Perkins, Patrick Boland, Steven J Cohen, et al.STAR Protocols|December 20, 2021
Preparation of mouse pancreatic tumor for single-cell RNA sequencing and analysis of the dataAizhan Surumbayeva, Michael Kotliar, Linara Gabitova-Cornell, et al.Cancer Biology & Therapy|October 12, 2010
Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents?Tetyana V Bagnyukova, Ilya G Serebriiskii, Yan Zhou, et al.Pageof 7